Outcome of Board Meeting

Medplus Health Services Limited September 10, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex Bandra (East), Mumbai – 400051 BSE Scrip Code: 543427 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Outcome of Board meeting under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) Pursuant to Regulation 30 of the Listing Regulations read with clause 1 of Para A of Part A of Schedule III, we wish to inform you that the Board of Directors of MedPlus Health Services Limited, at its meeting held today, i.e. Thursday, September 10, 2026, has considered and approved the acquisition of the residual stake i.e. 0.01% of the total shareholding of Optival Health Solutions Private Limited, a material subsidiary of the Company, from the remaining shareholders. Subject to completion of aforesaid acquisition, the Company’s shareholding in Optival Health Solutions Private Limited will increase from 99.99% to 100% and Optival Health Solutions Private Limited will consequently become a wholly owned subsidiary (WoS) of the Company. The detailed disclosure in accordance with the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, about the aforesaid acquisition is enclosed herewith as Annexure-A. The meeting commenced at 11:00 AM and concluded at 1:00 PM. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Shrenik Soni Company Secretary & Compliance Officer (M. No. F12400) Encl: a/a 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com Medplus Health Services Limited Annexure-A Details under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. Particulars Details 1. Name of the target entity, details in brief Optival Health Solutions Private Limited (material such as size, turnover etc. subsidiary of MedPlus) Information as on March 31, 2026: Authorised Share Capital: Rs. 210 Crore Paid-up share capital: Rs. 209.80 Crore Turnover for FY 2025-26: Rs.6816.44 Crore 2. Whether the acquisition would fall No; the proposed acquisition is not a related party within related party transaction(s) and transaction. Optival Health Solutions Private Limited whether the promoter/ promoter (target entity) is a subsidiary of MedPlus and the group/ group companies have any existing shareholders, from whom residual stake is interest in the entity being acquired? being acquired, are not related to the MedPlus and promoters or promoter group of the Company. If yes, nature of interest and details thereof and whether the same is done at No direct interest of promoter/ promoter group/ “arm’s length” group companies, except to the extent of the holding of MedPlus in Optival and directorships of promoter. 3. Industry to which the entity being Pharmacy Retail acquired belongs 4. Objects and impact of acquisition. To acquire 0.01% residual stake in Optival Health Solutions Private Limited, thereby making it wholly (Including but not limited to, disclosure owned subsidiary of the Company. of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) 5. Brief details of any governmental or Not Applicable regulatory approvals required for the acquisition 6. Indicative time period for completion of The acquisition is expected to be completed at the the acquisition earliest, subject to completion of requisite documentation and dematerialization/transmission formalities as applicable for remaining shareholders. The Company will take necessary steps to complete the acquisition expeditiously, subject to completion of the requisite formalities. 7. Consideration - whether cash Cash Consideration consideration or share swap or any other form and details of the same 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com Medplus Health Services Limited 8. Cost of acquisition and/ or the price at 17,986 equity shares of Face Value Rs.10 each, for an which the shares are acquired aggregate consideration of Rs.1.10 Crore or such other consideration amount as may be negotiated and agreed upon mutually between the parties. 9. Percentage of shareholding/ control 0.01% consisting of 17,986 equity shares of Optival acquired and/ or number of shares Health Solutions Private Limited. acquired 10. Brief background about the entity Optival Health Solutions Private Limited was acquired in terms of products/ line of incorporated on July 11, 2005, operating in Pharmacy business acquired, date of retail business. The Company is having its registered incorporation, history of last 3 years office situated at Hyderabad, Telangana. turnover, country in which the acquired entity has presence and any other Optival is a 99.99% subsidiary of MedPlus and is significant information (in brief) classified as a material subsidiary of MedPlus. The turnover for the previous three financial years is as below: FY 2025-26: Rs. 6816.44 Crore FY 2024-25: Rs. 6058.59 Crore FY 2024-26: Rs. 5573.08 Crore Country in which the acquired entity has presence: India 040-6724 6724 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com